HEADER ANTIMICROBIAL PROTEIN 11-APR-09 2KHT TITLE NMR STRUCTURE OF HUMAN ALPHA DEFENSIN HNP-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEUTROPHIL DEFENSIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 65-94; COMPND 5 SYNONYM: HNP-1, HP-1, HP1, DEFENSIN, ALPHA 1, HP 1-56, NEUTROPHIL COMPND 6 DEFENSIN 2, HNP-2, HP-2, HP2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DEF1, DEFA1, DEFA2, MRS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-2T KEYWDS MICROCRYSTALLINE PROTEIN, HUMAN ALPHA DEFENSIN, DEFENSIN, SECRETED, KEYWDS 2 ANTIBIOTIC, ANTIVIRAL DEFENSE, FUNGICIDE, PHOSPHOPROTEIN, KEYWDS 3 ANTIMICROBIAL PROTEIN EXPDTA SOLID-STATE NMR NUMMDL 10 AUTHOR Y.ZHANG,S.LI,T.F.DOHERTY,J.LUBKOWSKI,W.LU,J.LI,C.BARINKA,M.HONG REVDAT 5 01-MAY-24 2KHT 1 REMARK REVDAT 4 26-FEB-20 2KHT 1 REMARK REVDAT 3 05-FEB-14 2KHT 1 EXPDTA VERSN REVDAT 2 07-APR-10 2KHT 1 JRNL REVDAT 1 09-FEB-10 2KHT 0 JRNL AUTH Y.ZHANG,T.DOHERTY,J.LI,W.LU,C.BARINKA,J.LUBKOWSKI,M.HONG JRNL TITL RESONANCE ASSIGNMENT AND THREE-DIMENSIONAL STRUCTURE JRNL TITL 2 DETERMINATION OF A HUMAN ALPHA-DEFENSIN, HNP-1, BY JRNL TITL 3 SOLID-STATE NMR. JRNL REF J.MOL.BIOL. V. 397 408 2010 JRNL REFN ISSN 0022-2836 JRNL PMID 20097206 JRNL DOI 10.1016/J.JMB.2010.01.030 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH 2.21, UCSF-CHIMERA 1.3 REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE (X-PLOR REMARK 3 NIH), PETTERSEN, E.F., GODDARD, T.D., HUANG, C.C., REMARK 3 COUCH, G.S., GREENBLATT, D.M., MENG, E.C., AND REMARK 3 FERRIN, T.E (UCSF-CHIMERA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KHT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAY-09. REMARK 100 THE DEPOSITION ID IS D_1000101138. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 268; 253 REMARK 210 PH : 6.5; 6.5 REMARK 210 IONIC STRENGTH : NULL; NULL REMARK 210 PRESSURE : 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : POLYCRYSTALLINE SAMPLE GROWN REMARK 210 FROM 60% W/V PEG400, 30 MM REMARK 210 CACODYLATE, 60 MM LITHIUM SULFATE REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 13C-13C DARR 40 MS, 100 MS & REMARK 210 200 MS; 2D 15N-15N PDSD 3 S; 2D REMARK 210 CM5RR 0.8 MS & 1.5 MS; 2D CHHC REMARK 210 200 US & 300 US; 3D 15N-13C-13C REMARK 210 NCACX; 3D 15N-13C-13C NCOCX; 2D REMARK 210 15N-13C NCX REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY 3.113, TOPSPIN 1.3 REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING, SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 217 REMARK 217 SOLID STATE NMR STUDY REMARK 217 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLID REMARK 217 STATE NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 217 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 217 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 7 72.65 -46.04 REMARK 500 1 CYS A 9 69.81 -58.63 REMARK 500 1 ALA A 11 -164.90 -54.01 REMARK 500 2 PRO A 7 85.27 -47.19 REMARK 500 2 CYS A 9 68.95 -56.66 REMARK 500 2 TYR A 16 -95.33 -146.65 REMARK 500 2 GLN A 22 15.61 50.17 REMARK 500 3 PRO A 7 76.27 -47.86 REMARK 500 3 ALA A 8 110.36 -175.02 REMARK 500 3 TYR A 16 -103.29 -148.55 REMARK 500 3 GLN A 22 13.74 52.32 REMARK 500 4 PRO A 7 24.66 -61.82 REMARK 500 4 CYS A 9 99.29 -62.85 REMARK 500 4 TYR A 16 -99.15 -148.63 REMARK 500 4 GLN A 22 12.39 51.87 REMARK 500 5 PRO A 7 90.79 -47.40 REMARK 500 5 CYS A 9 76.76 -57.52 REMARK 500 6 PRO A 7 -6.18 -48.90 REMARK 500 6 CYS A 9 5.19 155.25 REMARK 500 6 TYR A 16 -101.70 -102.08 REMARK 500 6 GLN A 22 21.42 49.10 REMARK 500 7 PRO A 7 95.39 -46.93 REMARK 500 7 CYS A 9 75.97 -54.37 REMARK 500 7 TYR A 16 -65.15 -108.10 REMARK 500 7 GLN A 22 12.54 55.69 REMARK 500 8 PRO A 7 75.31 -46.20 REMARK 500 8 ALA A 8 109.16 -174.91 REMARK 500 8 TYR A 16 -72.48 -147.22 REMARK 500 8 GLN A 22 12.29 56.58 REMARK 500 9 PRO A 7 54.88 -50.86 REMARK 500 9 ALA A 8 101.82 -175.14 REMARK 500 9 CYS A 9 -8.24 151.36 REMARK 500 9 TYR A 16 -91.16 -147.41 REMARK 500 9 GLN A 22 12.18 59.76 REMARK 500 10 PRO A 7 87.05 -47.79 REMARK 500 10 ALA A 8 -160.90 -167.76 REMARK 500 10 CYS A 9 70.46 -54.63 REMARK 500 10 TYR A 16 -106.87 -147.19 REMARK 500 10 GLN A 22 12.75 52.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 16254 RELATED DB: BMRB DBREF 2KHT A 1 30 UNP Q6EZF6 DEF1_HUMAN 65 94 SEQRES 1 A 30 ALA CYS TYR CYS ARG ILE PRO ALA CYS ILE ALA GLY GLU SEQRES 2 A 30 ARG ARG TYR GLY THR CYS ILE TYR GLN GLY ARG LEU TRP SEQRES 3 A 30 ALA PHE CYS CYS CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1